Samil Pharmaceutical Co.,Ltd (000520.KS)
000520.KS Stock Price Chart
Explore Samil Pharmaceutical Co.,Ltd interactive price chart. Choose custom timeframes to analyze 000520.KS price movements and trends.
000520.KS Company Profile
Discover essential business fundamentals and corporate details for Samil Pharmaceutical Co.,Ltd (000520.KS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
4 Jan 2000
Employees
585.00
Website
https://www.samil-pharm.comCEO
Kang Huh
Description
Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of indispensable medicines in South Korea. It offers hepatic, gastrointestinal, vasodilator, antithrombotic, respiratory, skeletal muscle relaxants, circulatory, neurological, antibiotics, metabolic, antihistamines, immunosuppressive, hormone, anti-tumor, urinary, and ophthalmic drugs, as well as antipyretic, analgesic, and anti-inflammatory agents. The company also provides OTC products and sanitary aids. Samil Pharmaceutical Co.,Ltd was founded in 1947 and is headquartered in Seoul, South Korea.
000520.KS Financial Timeline
Browse a chronological timeline of Samil Pharmaceutical Co.,Ltd corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 30 Jun 2025
EPS came in at -₩306.25 , while revenue for the quarter reached ₩53.79B .
Earnings released on 15 May 2025
EPS came in at -₩428.00 , while revenue for the quarter reached ₩52.29B .
Earnings released on 3 Feb 2025
EPS came in at -₩181.65 , while revenue for the quarter reached ₩57.79B .
Earnings released on 14 Nov 2024
EPS came in at -₩40.91 , while revenue for the quarter reached ₩53.32B .
Earnings released on 14 Aug 2024
EPS came in at ₩21.19 , while revenue for the quarter reached ₩54.29B .
Earnings released on 14 May 2024
EPS came in at -₩118.07 , while revenue for the quarter reached ₩54.30B .
Earnings released on 30 Dec 2023
EPS came in at ₩61.82 , while revenue for the quarter reached ₩50.52B .
Earnings released on 14 Nov 2023
EPS came in at -₩46.12 , while revenue for the quarter reached ₩51.63B .
Earnings released on 11 Aug 2023
EPS came in at ₩52.87 , while revenue for the quarter reached ₩48.46B .
Earnings released on 15 May 2023
EPS came in at ₩54.61 , while revenue for the quarter reached ₩45.74B .
Stock split effective on 24 Mar 2023
Shares were split 11 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 19 Jan 2023
EPS came in at ₩142.59 , while revenue for the quarter reached ₩43.46B .
Earnings released on 14 Nov 2022
EPS came in at -₩152.00 , while revenue for the quarter reached ₩45.40B .
Earnings released on 12 Aug 2022
EPS came in at -₩19.68 , while revenue for the quarter reached ₩44.97B .
Earnings released on 10 May 2022
EPS came in at ₩26.83 , while revenue for the quarter reached ₩45.85B .
Earnings released on 31 Dec 2021
EPS came in at -₩247.21 , while revenue for the quarter reached ₩34.30B .
Dividend declared on 29 Dec 2021
A dividend of ₩80.00 per share was announced, adjusted to ₩72.73. The dividend was paid on 12 Apr 2022.
Earnings released on 23 Nov 2021
EPS came in at -₩120.00 , while revenue for the quarter reached ₩33.80B .
Earnings released on 14 Aug 2021
EPS came in at -₩83.64 , while revenue for the quarter reached ₩33.93B .
Earnings released on 18 May 2021
EPS came in at ₩46.88 , while revenue for the quarter reached ₩32.22B .
Stock split effective on 12 Apr 2021
Shares were split 2 : 1 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 Dec 2020
EPS came in at -₩44.79 , while revenue for the quarter reached ₩30.02B .
Dividend declared on 29 Dec 2020
A dividend of ₩150.00 per share was announced, adjusted to ₩68.18. The dividend was paid on 9 Apr 2021.
Earnings released on 14 Nov 2020
EPS came in at -₩17.73 , while revenue for the quarter reached ₩31.11B .
000520.KS Stock Performance
Access detailed 000520.KS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.